Multimodality imaging demonstrates trafficking of liposomes preferentially to ischemic myocardium.
暂无分享,去创建一个
A. Arai | S. Epstein | S. Anderson | R. Waksman | M. Lipinski | J. Frias | R. O. Escárcega | M. Albelda | D. Luger | P. Westman | David G Hellinga | Dror Luger | R. Waksman | J. Frías
[1] H. Krumholz,et al. National Trends in Heart Failure Hospitalization After Acute Myocardial Infarction for Medicare Beneficiaries: 1998–2010 , 2013, Circulation.
[2] K. Nicolay,et al. Passive targeting of lipid-based nanoparticles to mouse cardiac ischemia-reperfusion injury. , 2013, Contrast media & molecular imaging.
[3] A. Gabizon,et al. Polyethylene Glycol-Coated (Pegylated) Liposomal Doxorubicin , 2012, Drugs.
[4] K. Nicolay,et al. Contrast‐enhanced MRI of murine myocardial infarction – Part I , 2012, NMR in biomedicine.
[5] K. Nicolay,et al. Contrast‐enhanced MRI of murine myocardial infarction – Part II , 2012, NMR in biomedicine.
[6] Tal Dvir,et al. Nanoparticles targeting the infarcted heart. , 2011, Nano letters.
[7] J. Leor,et al. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair , 2011, Proceedings of the National Academy of Sciences.
[8] G. Dai,et al. Abstract 593: Molecular MRI of Cardiomyocyte Apoptosis With Simultaneous Delayed Enhancement MRI Distinguishes Apoptotic and Necrotic Myocytes in vivo: Potential for Midmyocardial Salvage in Acute Ischemia , 2009 .
[9] Parkson Lee-Gau Chong,et al. Targeting VEGF‐encapsulated immunoliposomes to MI heart improves vascularity and cardiac function , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] 高濱 博幸. Prolonged Targeting of Ischemic/reperfused Myocardium by Liposomal Adenosine Augments Cardioprotection in Rats , 2009 .
[11] C. Higgins,et al. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. , 1997, Journal of the American College of Cardiology.
[12] A. Gabizon,et al. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. , 1997, Drugs.
[13] V. Torchilin,et al. Plug and seal: Prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes , 1995, Nature Medicine.
[14] L. Horwitz,et al. Time course of coronary endothelial healing after injury due to ischemia and reperfusion. , 1994, Circulation.
[15] G. Koretzky,et al. CD45 and the immune response. , 1993, Journal of the American Society of Nephrology : JASN.
[16] V. Vetvicka,et al. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions , 1993, Clinical and experimental immunology.
[17] L. Horwitz,et al. Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. , 1990, Circulation research.